Acta Chir Orthop Traumatol Cech. 2017; 84(5):323-329 | DOI: 10.55095/achot2017/049

Proximal Femoral Fractures and Anticoagulation Therapy - When Is Surgery Safe?Current concepts review

A. GÄNSSLEN1,*, S. GRECHENIG2, W. GRECHENIG3
1 Klinik für Unfallchirurgie, Orthopädie und Handchirurgie, Klinikum Wolfsburg, Wolfsburg, Germany
2 Klinik und Poliklinik für Unfallchirurgie, Universitätsklinikum Regensburg, Regensburg, Germany
3 Universitätsklinik für Unfallchirurgie, LKH-Universitäts-Klinikum Graz, Graz, Austria

Patients presenting with proximal femur fractures are at high risk of developing DVT and pulmonary embolism. Many of these patients suffer from additional anticoagulant treatment. Patients on anticoagulation treatment are complex to manage, especially regarding timing of surgery due to implemented quality control recommendations. The present review analyses the present data timing of surgery and perioperative surgical considerations on anticoagulation treatment in this patients group.

Published: October 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
GÄNSSLEN A, GRECHENIG S, GRECHENIG W. Proximal Femoral Fractures and Anticoagulation Therapy - When Is Surgery Safe? Acta Chir Orthop Traumatol Cech. 2017;84(5):323-329. doi: 10.55095/achot2017/049. PubMed PMID: 29351532.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahmed I, Khan A, Nayak V, Mohsen A. An evidence-based warfarin management protocol reduces surgical delay in hip fracture patients. J Orthopaed Traumatol. 2014;15:21-27. Go to original source... Go to PubMed...
    2. Apixaban. Eliquis® (Apixaban): aktuelle Schweizer Fachinformation auf http://www.swissmedicinfo.ch. 2016.
    3. Barrett Y, Wang Z, Frost C, Shenker A. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay. Thromb Haemost. 2010;104:1263-1271. Go to original source... Go to PubMed...
    4. Barton T, Gleeson R, Topliss C, Greenwood R, Harries W, Chesser T. A comparison of the long gamma nail with the sliding hip screw for the treatment of AO/OTA 31-A2 fractures of the proximal part of the femur: a prospective randomized trial. J Bone Joint Surg Am. 2010;92:792-798. Go to original source... Go to PubMed...
    5. Brilakis E, Banerjee S, Berger P. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007;49:2145-2150. Go to original source... Go to PubMed...
    6. Bucking B, Bliemel C, Waschnick L, Balzer-Geldsetzer M, Dodel R, Slonka J, Ruchholtz S, Struwer J. Gerinnungshemmende Medikation bei proximaler Femurfraktur. Prospektive Validierungsstudie einer neuen institutionellen Leitlinie. Unfallchirurg. 2013;16:909-915. Go to original source... Go to PubMed...
    7. Burger W, Chemnitius J, Kneissl G, Rückers G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Int Med. 2005;257:399-414. Go to original source... Go to PubMed...
    8. Chechik O, Amar E, Khashan M, Kadar A, Rosenblatt Y, Maman E. In support of early surgery for hip fractures sustained by elderly patients taking clopidogrel - a retrospective study. Drugs Aging. 2012;29:63-68. Go to original source... Go to PubMed...
    9. Chechik O, Thein R, Fichman G, Haim A, Tov T, Steinberg E. The effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury. 2011;42:1277-1282. Go to original source... Go to PubMed...
    10. Collinge C, Kelly K, Little B, Weaver T, Schuster R. The Effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J Orthop Trauma. 2012;26:568-573. Go to original source... Go to PubMed...
    11. Collyer T, Reynolds H, Truyens E, Kilshaw L, Corcoran T. Perioperative management of clopidogrel therapy: the effects on in-hospital cardiac morbidity in older patients with hip fractures. Br J Anaesth. 2011;107:911-915. Go to original source... Go to PubMed...
    12. Doleman B, Moppett I. Is early hip fracture surgery safe for patients on clopidogrel? Systematic review, meta-analysis and meta-regression. Injury. 2015;46:954-962. Go to original source... Go to PubMed...
    13. Douketis J. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood. 2011;117:5044-5049. Go to original source... Go to PubMed...
    14. Douketis J, Berger P, Dunn A, Jaffer A, Spyropoulos A, Becker R, Ansell J. The perioperative management of antithrombotic therapy: American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:299-339. Go to original source...
    15. Expert. Expert opinion based on recent Eliquis® (Apixaban). EU product information; http://www.ema.europa.eu/ema/. 2016.
    16. Feely M, Mabry T, Lohse C, Sems S, Mauck K. Safety of clopidogrel in hip fracture surgery. Mayo Clin Proc. 2013;88:149-156. Go to original source... Go to PubMed...
    17. Fleisher L, Beckman J, Brown K. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2008;106:685-712. Go to original source... Go to PubMed...
    18. Frost C. Effects of Age and gender on the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) of Apixaban. Poster presented at International Society on Thrombosis and Haemostasis. July, 11-16 2009; Boston, USA, 2009.
    19. Ginsel B, Taher A, Whitehouse S, Bell J, Pulle C, Crawford R. Effects of anticoagulants on outcome of femoral neck fracture surgery. J Orthop Surg. 2015;23:29-32. Go to original source... Go to PubMed...
    20. Graham I, Atar D, Borch-Johnsen K, Boysen G. European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375-2414. Go to original source... Go to PubMed...
    21. Grines C, Bonow R, Casey D. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association. American College of Cardiology, Society for Cardiovascular Angiography and Interventions American College of Surgeons and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;49:734-739. Go to original source... Go to PubMed...
    22. Group FS. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis. Arch Cardiovasc Dis 2011. 104.669-676. Go to original source... Go to PubMed...
    23. Hamlet W, Lieberman J and Freedman E. Influence of health status and the timing of surgery on mortality in hip fracture patients. Am J Orthop. 1997;26:621-627.
    24. Himmelmann A. Rasche Aufhebung der oralen Antikoagulation - häufige Notfallsituationen. Schweiz Med Forum. 2013;3:797-800. Go to original source...
    25. Hossain F, Rambani R, Ribee H, Koch L. Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties. J Orthopaed Traumatol. 2013;14:171-177. Go to original source... Go to PubMed...
    26. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiori GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130. Go to original source... Go to PubMed...
    27. Kennedy M, Roche S, Fleming S, Lenehan B, Curtin W. The association between aspirin and blood loss in hip fracture patients. Acta Orthop Belg. 2006;72:29-33. Go to PubMed...
    28. Kozek S, Gutl M, Illievich U, Pachucki A, Kwasny O, Giurea A, Haushofer A, Watzke H. Klinischer Pfad - Behandlung huftnaher Frakturen bei zuvor oral antikoagulierten Patientinnen und Patienten inkl. Ergänzungen. Bundesministerium fur Gesundheit, Radetzkystraße 2, 1030 Wien, 2016. (Download: 09.08.2016: http://www.lknoe.at/fileadmin/media_data/Dateien/Holding/Abteilungen/Medizinische_Betriebsunterstuetzung/Klinischer_Pfad_Behandlung_h%C3%BCftnaher_Frakturen_bei_zuvor_oral_antikoagulierten_Patientinnen_und_Patienten_Stand_M%C3%A4rz_2016.pdf.)
    29. Kragh A, Waldén M, Apelqvist A, Wagner P, Atroshi I. Bleeding and first-year mortality following hip fracture surgery and preoperative use of lowdose acetylsalicylic acid: an observational cohort study. BMC Musculoskeletal Disorders. 2011;12:254. Go to original source... Go to PubMed...
    30. Levi M. Emergency reversal of antithrombotic treatment. Intern Emerg Med. 2009;4:137-145. Go to original source... Go to PubMed...
    31. Maheshwari R, Acharya M, Monda M, Pandey R. Factors influencing mortality in patients on antiplatelet agents presenting with proximal femoral fractures. J Orthop Surg. 2011;19:314-316. Go to original source... Go to PubMed...
    32. Manaqibwala M, Btler K, Sagebien C. Complications of hip fracture surgery on patients receiving clopidogrel therapy. Acta Orthop Trauma Surg. 2014;134:747-753. Go to original source... Go to PubMed...
    33. Mendelson D, Friedman S. Principles of comanagement and the geriatric fracture center. Clin Geriatr Med. 2014;30:183-189. Go to original source... Go to PubMed...
    34. Mereddy P, Kamath S, Ramakrishnan M, Malik H, Donnachie N. The AO/ASIF proximal femoral nail antirotation (PFNA): a new design for the treatment of unstable proximal femoral fractures. Injury. 2009;40:428-432. Go to original source... Go to PubMed...
    35. Muhm M, Hillenbrand H, Danko T, Weiss C, Ruffing T, Winkler H. Fruhkomplikationsrate bei huftgelenknahen Frakturen. Abhängigkeit von der Versorgung im Bereitschaftsdienst und von Nebenerkrankungen. Unfallchirurg. 2013;118:336-346. Go to original source... Go to PubMed...
    36. Muhm M, Walendowski M, Danko T, Weiss C, Ruffing T, Winkler H. Einflussfaktoren auf den stationären Verlauf von Patienten mit huftgelenknahen Femurfrakturen. Komplikationen Liegezeit und Krankenhaussterblichkeit. Z Gerontol Geriatr. 2015;48:339-345. Go to original source... Go to PubMed...
    37. Müller-Mai C, Schulze Raestrup U, Kostuj T, Dahlhoff G, Günster C, Smektala R. Einjahresverläufe nach proximalen Femurfrakturen. Poststationäre Analyse von Letalität und Pflegestufen durch Kassendaten. Unfallchirurg. 2015;118:780-794. Go to original source... Go to PubMed...
    38. Neuerburg C, Gosch M, Böcker W, Blauth M, Kammerlander C. Huftgelenknahe Femurfrakturen des älteren Menschen. Z Gerontol Geriatr. 2015;48:647-661. Go to original source... Go to PubMed...
    39. ÖGARI. Direkte Orale Anti-Koagulantien (DOAK) in internistischer Dauertherapie*. APIXABAN (ELIQUIS ®) / DABI - GATRAN (PRADAXA®) / RIVAROXABAN (XARELTO®). Management im klinischen Alltag. Empfehlungen der Arbeitsgruppe Peri operative Gerinnung der ÖGARI (2015). https://www.oegari.at/web_files/dateiarchiv/editor/doak-management-agpg-03-2015-taschenkittelversion_mit_labor.pdf. (Download 20.10.2016), 2015.
    40. Poldermans D, Bax J, Boersma E. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J. 2009;30:2769-2812. Go to original source... Go to PubMed...
    41. Rade J, Hogue CJ. Noncardiac surgery for patients with coronary artery stents: timing is everything. Anesthesiology. 2008;109:573-575. Go to original source... Go to PubMed...
    42. Rahmann A. New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents. Austr Fam Phys. 2014;43:861-866.
    43. Sandmann G, Biberthaler P. Pertrochantäre Femurfrakturen beim geriatrischen Patienten. Unfallchirurg. 2015;118:447-462. Go to original source... Go to PubMed...
    44. Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121:3554-3562. Go to original source... Go to PubMed...
    45. Schlitt A, Jámbor C, Spannagl M, Gogarten W, Schilling T, Zwißler B. The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors. Dtsch Arztebl Int. 2013;110:525-532. Go to original source... Go to PubMed...
    46. Schouten O, van Domburg R, Bax J. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol. 2007;49:122-124. Go to original source... Go to PubMed...
    47. Spahn D, Borgeat A, Kern C, Korte W, Mach F, Nedeltchev K, Ravussin P. Anwendung von Apixaban - Guidelines der Expertengruppe. (Download: 20.10.2016), 2016.
    48. van Ryn J, Stangier J, Haertter S, Liesenfeld K, Wienen W, Feuring M, Clemens A. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103:1116-1127. Go to original source... Go to PubMed...
    49. Wordsworth D, Halsey T, Griffiths R, Parker M. Clopidogrel has no effect on mortality from hip fracture. Injury. 2013;44:743-746. Go to original source... Go to PubMed...
    50. Zehir S, Zehir R, Sarak T. Early surgery is feasible in patients with hip fractures who are on clopidogrel therapy. Acta Orthop Traumatol Turc. 2015;49:249-254. Go to original source... Go to PubMed...
    51. Zuckerman J, Skovron M, Koval K. Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip. J Bone Joint Surg Am. 1995;77:1551-1556. Go to original source... Go to PubMed...

    Return to the content